NNVC is up 33% this week, from 0.75 to 1.00. But the good news is that the significance of Monday's announcement derived from LSU researchers has yet to register.
At $1.00 a share, NanoViricide's market cap is about $120M. As per the disclosure of success against Herpes, just one product (out of about eight in ongoing development) has a $2B market, with little or no competition.
I look at this as a gross undervaluation, a market anomaly that won't last for long.
8/12/09 Recent Headlines NanoViricides, Inc. Herpes Study Results Discussed on CBS News Report 7:00AM ET - Business Wire NanoViricides, Inc., reported today that the CBS affiliate TV station WBRZ interviewed Professor K. Gus Kousoulas, PhD, in which he explained the potential implications of the Company's nanoviricides anti-Herpes drug candidates. "Over 90% of the people are infected with Herpes, whether they know it or not," said Dr. Kousoulas, adding "it can manifest as cold sores or genital herpes. Read the details.
OT: Based on the extensive explanation in the linked piece above, I would say Bill has had his for a loooong time so isn't experiencing symptoms very often. Since he's the one that likely gave it to her, she's still pissed and due to the emotional stress is the one being treated. Just a theory but still bodes well for NNVC's treatment.
Hi Weine, Thanks for posting the last link. I am in full agreement with this article. I never had flu vaccine and will never have. Last sentence of the article is exactly what I am doing, the natural way. I will start having a closer look at NNVC now. Lili
Wow, reported on Drudge? Nice.
ReplyDeleteIs Drudge a well read site???
ReplyDeletewhat the hell, did she say they just received a 10 million$ grant... nice.. (soemthing the news presenter said right at the end...)
ReplyDeleteSee LSU clip via drudge website.
actually it was $11M. Awesome news!
ReplyDeleteAnd you can never underestimate the good fortune of accidental good PR!
ReplyDelete4 years ago NNVC went to $3.70 on speculation...Now we've got The Stuff..imagine where we are going now!!
ReplyDeleteNNVC is up 33% this week, from 0.75 to 1.00. But the good news is that the significance of Monday's announcement derived from LSU researchers has yet to register.
ReplyDeleteAt $1.00 a share, NanoViricide's market cap is about $120M. As per the disclosure of success against Herpes, just one product (out of about eight in ongoing development) has a $2B market, with little or no competition.
I look at this as a gross undervaluation, a market anomaly that won't last for long.
8/12/09
ReplyDeleteRecent Headlines
NanoViricides, Inc. Herpes Study Results Discussed on CBS News Report
7:00AM ET - Business Wire
NanoViricides, Inc., reported today that the CBS affiliate TV station WBRZ interviewed Professor K. Gus Kousoulas, PhD, in which he explained the potential implications of the Company's nanoviricides anti-Herpes drug candidates. "Over 90% of the people are infected with Herpes, whether they know it or not," said Dr. Kousoulas, adding "it can manifest as cold sores or genital herpes.
Read the details.
dorothy
Here's an interesting explanation of the Herpes virus.
ReplyDeletehttp://www.herpes.com/hsv1-2.html
I now better understand the importance of NNVC's revolutionary treatment.
Alan, what do u think of this headline...do u see this as a trend?? anybody's opinion is welcome!!
ReplyDeleteMajor Hedge Fund Closes: Even the "World's Best Business" Is Getting Tougher
http://finance.yahoo.com/tech-ticker/article/300048/Major-Hedge-Fund-Closes-Even-the-%22World%27s-Best-Business%22-Is-Getting-Tougher?tickers=ozm,fig,bx,xlf,skf,dia,spy&sec=topStories&pos=8&asset=&ccode=
another glorious morning for trading the trend.
ReplyDeletealmost as refreshing as viewing the Falls from the railing on the Canadian side on a sunny August morning.
-Mike
Is that Bill or Hillary that is being treated for their herpes?
ReplyDelete;-)
Greg
OT: Based on the extensive explanation in the linked piece above, I would say Bill has had his for a loooong time so isn't experiencing symptoms very often. Since he's the one that likely gave it to her, she's still pissed and due to the emotional stress is the one being treated. Just a theory but still bodes well for NNVC's treatment.
ReplyDeletewho is THERACOUR PHARMA, they seem to own 10% of nnvc
ReplyDeleteAnon, this post on investorhub might shed some light:
ReplyDeletehttp://investorshub.advfn.com/boards/read_msg.aspx?message_id=38351666
Regards,
Wayne
Crikey!! This can only bolster the case for our favorite "anti-vaccine".....
ReplyDeletehttp://www.newsmax.com/health/vaccine_swine_flu/2009/07/07/232717.html?CFID=550330&CFTOKEN=2584a75ebbd6340b-0DEA800D-19B9-CD82-8264A94E4CAE8D00
Regards,
Wayne
Hi Weine,
ReplyDeleteThanks for posting the last link. I am in full agreement with this article. I never had flu vaccine and will never have. Last sentence of the article is exactly what I am doing, the natural way. I will start having a closer look at NNVC now.
Lili